This month, the U.S. Food and Drug Administration published a study on the effectiveness of the GenomeTrakr Whole Genome Sequencing (WGS) Network, a scientific tool that helps the FDA detect, investigate and limit the spread
Continue Reading New study shows FDA Whole Genome Sequencing network provides nearly $500 million in annual health benefits
Scientists are urging government officials to consider helping to develop an international database to share and analyze DNA sequences.
Such a system is a platform for storing whole genome sequencing (WGS) data on the full
Continue Reading Experts call for global DNA database to help disease surveillance
Use of whole genome sequencing is extremely limited in most developing nations, according to a study.
Researchers found while some countries lack the capacity to collect and analyse the data generated from whole genome sequencing
Continue Reading WGS use on pathogens ‘extremely limited’ in developing countries
Editor’s note: This column by FDA’s Steven Musser and Eric L. Stevens was originally published on the agency’s blog.
To view the larger version of this graph on the FDA website,
Continue Reading WGS could be WMD in global battle against foodborne illness
Editor’s note: This article was originally posted on FDA’s Consumer Updates page. A person commits a crime, and the detective uses DNA evidence collected from the crime scene to track the criminal down. An
Continue Reading GenomeTrakr is FDA’s version of Hoover’s fingerprint file
